• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.美国东北部地区肝细胞癌 (HCC) 的风险因素:一项病例对照研究的结果。
Cancer Causes Control. 2020 Apr;31(4):321-332. doi: 10.1007/s10552-020-01277-1. Epub 2020 Feb 14.
2
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.中国河南地区乙型和丙型肝炎病毒感染作为肝细胞癌危险因素的病例对照研究。
Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574.
3
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.酒精、糖尿病和病毒性肝炎对美国黑人和白人肝细胞癌风险的协同作用
Cancer. 2004 Sep 1;101(5):1009-17. doi: 10.1002/cncr.20427.
4
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.肝细胞癌的危险因素:酒精与病毒性肝炎和糖尿病的协同作用。
Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780.
5
Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.在台湾南部乙型肝炎和丙型肝炎流行地区,糖尿病、代谢综合征和肥胖不是肝细胞癌的显著危险因素。
Kaohsiung J Med Sci. 2013 Aug;29(8):451-9. doi: 10.1016/j.kjms.2012.12.006. Epub 2013 Feb 9.
6
Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.纽约市肝细胞癌、病毒性肝炎的地理流行病学及社会经济地位
Cancer Causes Control. 2017 Jul;28(7):779-789. doi: 10.1007/s10552-017-0897-8. Epub 2017 Jun 1.
7
Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.实体器官移植后肝细胞癌的发病率及危险因素
Transplantation. 2008 Sep 27;86(6):784-90. doi: 10.1097/TP.0b013e3181837761.
8
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.丙型肝炎病毒(HCV)作为肝细胞癌危险因素的病例对照研究:HCV基因型的作用以及与乙型肝炎病毒和酒精的协同作用。布雷西亚肝细胞癌研究。
Int J Cancer. 1999 May 31;81(5):695-9. doi: 10.1002/(sici)1097-0215(19990531)81:5<695::aid-ijc4>3.0.co;2-w.
9
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.代谢因素与慢性乙型/丙型肝炎感染导致肝细胞癌的风险:台湾的一项随访研究
Gastroenterology. 2008 Jul;135(1):111-21. doi: 10.1053/j.gastro.2008.03.073. Epub 2008 Apr 4.
10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.

引用本文的文献

1
Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case-control study.路易斯安那州东南部肝细胞癌的临床风险因素:一项配对病例对照研究。
Cancer Causes Control. 2025 Jun 27. doi: 10.1007/s10552-025-02021-3.
2
High Plasma Alpha-Fetoprotein Level Is Associated With Early Postoperative Complications in Patients With Hepatocellular Carcinoma in Southern Vietnam During 2018-2023: A Cross-Sectional Study.2018 - 2023年越南南部肝细胞癌患者术后早期并发症与高血浆甲胎蛋白水平相关:一项横断面研究
Health Sci Rep. 2025 Apr 21;8(4):e70655. doi: 10.1002/hsr2.70655. eCollection 2025 Apr.
3
Insights in Molecular Therapies for Hepatocellular Carcinoma.肝细胞癌分子疗法的见解
Cancers (Basel). 2024 May 10;16(10):1831. doi: 10.3390/cancers16101831.
4
Detection of hepatocellular carcinoma methylation markers in salivary DNA.检测唾液 DNA 中的肝癌甲基化标记物。
Biosci Rep. 2024 Mar 29;44(3). doi: 10.1042/BSR20232063.
5
Trends in liver cancer mortality in China from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.中国 1990 年至 2019 年肝癌死亡率趋势:基于 2019 年全球疾病负担研究的系统分析。
BMJ Open. 2023 Dec 30;13(12):e074348. doi: 10.1136/bmjopen-2023-074348.
6
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition.增强肝癌治疗效果:创新性地将HDAC2抑制剂与PD-1/PD-L1抑制相结合。
Cancer Cell Int. 2023 Sep 16;23(1):203. doi: 10.1186/s12935-023-03051-0.
7
The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis.阿司匹林使用对肝细胞癌发病的影响——一项更新的系统评价与荟萃分析
Cancers (Basel). 2023 Jul 6;15(13):3518. doi: 10.3390/cancers15133518.
8
Molecular Ultrasound Imaging Depicts the Modulation of Tumor Angiogenesis by Acetylsalicylic Acid.分子超声成像描绘了乙酰水杨酸对肿瘤血管生成的调节作用。
Int J Mol Sci. 2023 Apr 11;24(8):7060. doi: 10.3390/ijms24087060.
9
CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment.钙信号调节蛋白 II 抑制剂:肝癌治疗中免疫检查点抑制剂的潜在增敏剂。
Front Immunol. 2023 Mar 16;14:1052657. doi: 10.3389/fimmu.2023.1052657. eCollection 2023.
10
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis.阿司匹林预防肝细胞癌的疗效与安全性:一项更新的荟萃分析。
J Clin Transl Hepatol. 2022 Oct 28;10(5):835-846. doi: 10.14218/JCTH.2021.00257. Epub 2022 Jan 17.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者与非非酒精性脂肪性肝病患者在接受肝细胞癌根治性治疗后的生存率。
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1061-1069. doi: 10.1111/apt.14342. Epub 2017 Sep 28.
3
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
4
Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013.美国全行业氯乙烯队列中氯乙烯的定量估计暴露量与肝血管肉瘤和肝细胞癌风险:截至2013年的死亡率更新
Occup Environ Med. 2017 Oct;74(10):709-716. doi: 10.1136/oemed-2016-104051. Epub 2017 May 10.
5
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.1980 - 2014年美国各县癌症死亡率差异的趋势与模式
JAMA. 2017 Jan 24;317(4):388-406. doi: 10.1001/jama.2016.20324.
6
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.2000年至2012年美国50个州肝细胞癌的发病率
Gastroenterology. 2017 Mar;152(4):812-820.e5. doi: 10.1053/j.gastro.2016.11.020. Epub 2016 Nov 23.
7
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝细胞癌
World J Gastroenterol. 2016 Oct 7;22(37):8294-8303. doi: 10.3748/wjg.v22.i37.8294.
8
Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.利用高脂、胆碱缺乏饮食和腹腔注射二乙基亚硝胺建立一种伴有非酒精性脂肪性肝炎的新型肝细胞癌小鼠模型。
BMC Gastroenterol. 2016 Jun 13;16(1):61. doi: 10.1186/s12876-016-0477-5.
9
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.一种饮食诱导的非酒精性脂肪性肝病和肝细胞癌动物模型。
J Hepatol. 2016 Sep;65(3):579-88. doi: 10.1016/j.jhep.2016.05.005. Epub 2016 May 31.
10
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.144万成年人的休闲时间体力活动与26种癌症风险的关联
JAMA Intern Med. 2016 Jun 1;176(6):816-25. doi: 10.1001/jamainternmed.2016.1548.

美国东北部地区肝细胞癌 (HCC) 的风险因素:一项病例对照研究的结果。

Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

机构信息

Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA.

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.

出版信息

Cancer Causes Control. 2020 Apr;31(4):321-332. doi: 10.1007/s10552-020-01277-1. Epub 2020 Feb 14.

DOI:10.1007/s10552-020-01277-1
PMID:32060838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7136513/
Abstract

PURPOSE

HCC incidence has been continuously rising in the US for the past 30 years. To understand the increase in HCC risk, we conducted a case-control study in Connecticut, New Jersey and part of New York City.

METHODS

Through rapid case ascertainment and random digit dialing, we recruited 673 incident HCC patients and 1,166 controls. Information on demographic and anthropometric characteristics, lifestyle factors, medical and family cancer histories, were ascertained through telephone interviews using a structured questionnaire. Saliva specimens were collected for testing hepatitis C virus (HCV) antibodies. Unconditional logistic regression models were utilized to calculate odds ratio (OR) and 95% confidence interval (CI) to determine HCC associations with risk factors.

RESULTS

The study confirmed that HCV infection and obesity were important risk factors for HCC, ORs 110 (95% CI 59.2-204) and 2.13 (95% CI 1.52-3.00), respectively. High BMI and HCV infection had synergy in association with elevated HCC risk. Patients both obese and infected with HCV had HCC detected on average nearly 10 years earlier than those with neither factor. Diabetes, cigarette smoking and heavy alcohol intake were all associated with increased risk of HCC, whereas aspirin and other NSAID use were associated with reduced risk. HCC cases tended to attain less education, with lower household incomes, unmarried, and to have had more sexual partners than the controls.

CONCLUSIONS

Individuals at risk of HCC in the US comprise a unique population with low socioeconomic status and unhealthy lifestyle choices. Given the multifactorial nature, a comprehensive approach is needed in HCC prevention.

摘要

目的

在过去的 30 年中,美国的 HCC 发病率一直在持续上升。为了了解 HCC 风险增加的原因,我们在康涅狄格州、新泽西州和纽约市的部分地区进行了一项病例对照研究。

方法

通过快速病例确定和随机数字拨号,我们招募了 673 名 HCC 患者和 1166 名对照。通过使用结构化问卷进行电话访谈,收集了人口统计学和人体测量特征、生活方式因素、医疗和家族癌症史方面的信息。采集唾液样本进行丙型肝炎病毒 (HCV) 抗体检测。利用非条件逻辑回归模型计算比值比 (OR) 和 95%置信区间 (CI),以确定 HCC 与危险因素的关联。

结果

该研究证实 HCV 感染和肥胖是 HCC 的重要危险因素,OR 分别为 110(95%CI 59.2-204)和 2.13(95%CI 1.52-3.00)。高 BMI 和 HCV 感染与 HCC 风险升高具有协同作用。同时感染 HCV 且肥胖的患者平均比既没有这些因素的患者早近 10 年被诊断出 HCC。糖尿病、吸烟和大量饮酒均与 HCC 风险增加相关,而阿司匹林和其他 NSAID 的使用与风险降低相关。与对照组相比,HCC 患者的受教育程度较低,家庭收入较低,未婚,性伴侣较多。

结论

美国 HCC 高危人群具有独特的特点,社会经济地位低,生活方式不健康。鉴于 HCC 的多因素性质,需要采取综合方法进行 HCC 预防。